SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001193125-23-236901
Filing Date
2023-09-18
Accepted
2023-09-18 16:05:27
Documents
5
Period of Report
2023-09-15

Document Format Files

Seq Description Document Type Size
1 PRE 14A d545310dpre14a.htm PRE 14A 247326
2 GRAPHIC g545310g40m34.jpg GRAPHIC 25465
3 GRAPHIC g545310g64q82.jpg GRAPHIC 36160
4 GRAPHIC g545310page001.jpg GRAPHIC 100722
5 GRAPHIC g545310page002.jpg GRAPHIC 94295
  Complete submission text file 0001193125-23-236901.txt   580013
Mailing Address 45 WIGGINS AVENUE BEDFORD MA 01730
Business Address 45 WIGGINS AVENUE BEDFORD MA 01730 781-430-8200
Stoke Therapeutics, Inc. (Filer) CIK: 0001623526 (see all company filings)

IRS No.: 471144582 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-38938 | Film No.: 231261229
SIC: 2834 Pharmaceutical Preparations